Tissue of Origin: Head-and-Neck Cancer
Cancer Type: Head-and-Neck Squamous Cell Carcinoma
MSK-921 is a human head-and-neck cancer cell line.
This cell line was established from a subject with head-and-neck squamous cell carcinoma.
- Peter G. Sacks, MD, former Associate Attending, Surgery, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Xu L., Davidson B.J., Murty V.V.V.S., Li R.-G., Sacks P.G., Garin-Chesa P., Schantz S.P., Chaganti R.S.K. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int. J. Cancer 59:383-387(1994) (PubMed ID 7927946).
This cell line may be licensed nonexclusively for research or commercial purposes.
- Express License: For internal research purposes by a for-profit entity: Fill out MSK’s Core Express License; see here for links to the online fillable Core Express License, as well as a PDF version. For detailed guidance on how to fill out this webform, see here. Please note: In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. This license is only available for select cell lines, including this one. Once this license has been executed by MSK, you will receive a signed copy and payment instructions; all payments up to $10,000 must be made by credit card.
- Commercial License: Contact MSK’s Tangible Research Materials team at [email protected].
- For non-licensing requests from academic-research institutions: Contact MSK’s Antibody & Bioresource Core Facility at [email protected].